Institutional investors hold a majority ownership of AMGN through the 77.52% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2019, these large investors purchased a net $1.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 1.1 Million shares of Amgen Inc
T. ROWE PRICE ASSOCIATES, INC. (... Bought 1.0 Million shares of Amgen Inc
MORGAN STANLEY & CO. LLC Bought 894.5 Thousand shares of Amgen Inc